The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

MoneyShow presents top investment ideas for 2024 from leading advisors. Part 10 includes Advanced Micro Devices, Novo Nordisk ...

Gil Roth, President of the Pharma & Biopharma Outsourcing Association, shared his insights in the CPHI Annual Report 2024, ...

For now, her focus is on making the most of its existing portfolio, notably Keytruda – the world’s top-selling cancer drug – ...

Trump's threat of imposing a tariff on Denmark over desires to acquire Greenland has caught the attention of one of the ...

With a biochemicals portfolio that aligns with Chinese development priorities, the company’s future in the local biotech ...

The cuts at two Massachusetts plants follow further site closures and layoffs across the company over the past few years.

J&J, AstraZeneca, Novo Nordisk and Roche are among the companies that might take a hit from the soon-to-be-enacted fees, ...

Eli Lilly and Novo Nordisk, can’t keep up with the demand for them. People who were morbidly obese or just slightly ...

AstraZeneca on Friday scrapped plans to invest 450 million pounds ($558.3 million) in its vaccine manufacturing plant in ...

Eyeing an expected leap in demand for contrast media—used in X-rays, CT scans and more—GE HealthCare is upping its stake in ...

Plant-derived proteins are booming in cosmetics for their natural, effective, and eco-friendly benefits, driving UK market growth amid rising beauty trends. Ankush Nikam Future Market Insights, Inc.